Dog /

Breed profile · FDA CVM July 2026 extract

Terrier - Bedlington adverse-event record

Adverse-event filings for Terrier - Bedlington (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

#259 of 510
by report volume (all breeds)
65
FDA CVM reports on file
7.7%
death-coded share of reports
#76 of 275
by death-coded share (≥50 reports)

How the 65 reports break down

By recorded gender -- every report on file for Terrier - Bedlington, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 13 9.75 6.5 3.25 0 2016 2017 2018 2019 2020 2022 2023 2025 Reports filed Death-coded reports
Annual report volume for Terrier - Bedlington drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Terrier - Bedlington ranks #255 of 510 by total reports (65) and #75 of 275 by death-coded share (7.7%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#255
This breed, reports of 510
#75
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Terrier - Bedlington has 65 reports now versus 64 in that prior snapshot: 1 more (1.6%).

Report change
+1
Death-coded reports
+0
Death-coded share
−0.1 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Terrier - Bedlington changes

Total Reports

65

Below-median volume

Deaths Reported

5

of 65 reports

Death-coded share of reports

7.7%

Above-median death-coded share

Avg Age at Report

7.0 yr

9.0 kg avg weight

Death-Coded Outcome Share

Terrier - Bedlington death-coded reports 7.7%
Cross-breed median

7.7% of 65 terrier - bedlington reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Terrier - Bedlington's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

8% 72nd percentile Higher share than 72% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Terrier - Bedlington 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Average weight at time of report: 9.0 kg (19.8 lbs)

Top Reported Reactions

Vomiting 11
Emesis 8
Lethargy (see also Central nervous system depression in 'Neurological') 8
Seizure NOS 7
Anorexia 6

Most Referenced Drugs

Milbemycin Oxime + Spinosad 9
Fluralaner Chew Tablets 8
Spinosad 7
Afoxolaner 5
Nitenpyram 4

Outcome Breakdown

Recovered/Normal
25 (41.0%)
Outcome Unknown
15 (24.6%)
Ongoing
14 (23.0%)
Euthanized
3 (4.9%)
Died
2 (3.3%)
Recovered with Sequela
2 (3.3%)

Gender Distribution

Female 34 (52.3%)
Male 31 (47.7%)

Reports by Year

Year Reports Trend
2010 2
2011 5
2012 6
2013 6
2014 1
2015 6
2016 8
2017 13
2018 4
2019 5
2020 4
2022 1
2023 1
2025 3

Terrier - Bedlington: high death-coded share in the FDA CVM extract

Signature read: Terrier - Bedlington's 7.7% death-coded share is in the upper third of the ≥50-report cohort (median 4.8%). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Terrier - Bedlington sits at #259 of 510 by report volume among all breeds and #185 of 298 among dog breeds, with 65 reports and 5 (7.7%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #76 of 275. Mean age at report: 7.0 years, average weight 9.0 kg (19.8 lbs).

Top reported signs: Vomiting (11), Emesis (8), Lethargy (see also Central nervous system depression in 'Neurological') (8). Most-referenced drug: Milbemycin Oxime + Spinosad (9 reports), followed by Fluralaner Chew Tablets (8) and Spinosad (7).

Outcome coding on 61 status-recorded reports is dominated by Recovered/Normal (41.0%). Annual submissions ranged 1-2,025 across 14 years on file.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

Two openFDA-derived peer sets for Terrier - Bedlington, both outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (7.7% death-coded here).

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Terrier - Bedlington?
There are 65 adverse event reports involving Terrier - Bedlington in the FDA database, of which 5 were death-coded (7.7% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Terrier - Bedlington ranks #259 of 510 by report volume among all breeds PlainBreed indexes (#185 of 298 among dog breeds).
Where does Terrier - Bedlington sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Terrier - Bedlington is #259 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #185 of 298. Among breeds with at least 50 reports, its death-coded share ranks #76 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Terrier - Bedlington?
The most commonly reported adverse reactions for Terrier - Bedlington are Vomiting (11 reports), Emesis (8 reports), Lethargy (see also Central nervous system depression in 'Neurological') (8 reports), Seizure NOS (7 reports), Anorexia (6 reports).
What drugs are most frequently associated with Terrier - Bedlington adverse events?
The drugs most frequently referenced in Terrier - Bedlington adverse event reports are Milbemycin Oxime + Spinosad (9 reports), Fluralaner Chew Tablets (8 reports), Spinosad (7 reports), Afoxolaner (5 reports), Nitenpyram (4 reports).
What is the average age of Terrier - Bedlington in adverse event reports?
The average age of Terrier - Bedlington at the time of adverse event reports is 7.0 years, with an average weight of 9.0 kg (19.8 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Terrier - Bedlington (Dog), extract as of July 2026 extract. 65 reports · 5 death-coded (7.7% of reports, not a mortality rate) · #259 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →